Stegmayr Birgitta, Eriksson Marie, Asplund Kjell
Department Public Health and Clinical Medicine, Umeå University Hospital, SE-901 85 Umeå, Sweden.
Stroke. 2004 Sep;35(9):2059-63. doi: 10.1161/01.STR.0000138451.07853.b6. Epub 2004 Jul 22.
Northern Sweden has one of the highest incidence rates of subarachnoid hemorrhage (SAH) among the populations covered by the WHO MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) Project, approximately twice as high as in the other populations in Europe. In this study, trends in incidence, 28-day case fatality (CF), and mortality in SAH were followed over a 16-year period.
Since 1985, all SAHs in northern Sweden among patients 25 to 74 years old have been validated using strict MONICA criteria. From 1985 through 2000, 392 men and 592 women had SAH. During 3 years, 1997 to 1999, SAH among those aged 75 and older were also included.
The total incidence among those 25 years and older was 13.3 per 100 000 in men and 24.4 per 100 000 in women. During the 16 years of observation, age standardized incidence in the group aged 25 to 74 years decreased significantly in men (P for trend <0.0001) but remained essentially unchanged in women (P for trend=0.64). The 28-day CF for all years was 36.5% in men, with no significant trend (P=0.7). In women, average CF was 35%, with a significant decline (P=0.003). The annual mortality decreased significantly in both sexes (by 3.87 [95% CI+/-2.75 percentage points] in men and 3.97 [95% CI+/-2.29] in women).
The decline in SAH mortality has different explanations in men (declining incidence) and in women (declining CF).
在世界卫生组织MONICA(心血管疾病趋势和决定因素监测)项目覆盖的人群中,瑞典北部是蛛网膜下腔出血(SAH)发病率最高的地区之一,大约是欧洲其他地区人群的两倍。在本研究中,对SAH的发病率、28天病死率(CF)和死亡率在16年期间的变化趋势进行了跟踪。
自1985年以来,瑞典北部25至74岁患者的所有SAH病例均按照严格的MONICA标准进行了验证。1985年至2000年期间,有392名男性和592名女性发生SAH。在1997年至1999年的3年期间,75岁及以上人群的SAH病例也被纳入。
25岁及以上人群中,男性的总发病率为每10万人中有13.3例,女性为每10万人中有24.4例。在16年的观察期内,25至74岁年龄组中,男性的年龄标准化发病率显著下降(趋势P<0.0001),而女性基本保持不变(趋势P=0.64)。所有年份男性的28天CF为36.5%,无显著趋势(P=0.7)。女性的平均CF为35%,呈显著下降趋势(P=0.003)。两性的年死亡率均显著下降(男性下降3.87[95%CI±2.75个百分点],女性下降3.97[95%CI±2.29])。
SAH死亡率的下降在男性(发病率下降)和女性(CF下降)中有不同的原因。